Disclosed is a preparation, for use in the production of inks for transfer printing, which preparation comprises, in intimate admixture, a disperse dye and/or dispersion optical brightener, sublimable in the range of from 180.degree. to 220.degree. C, and a dispersing aid being a compound of formula I, ##STR1## in which R.sub.1, R.sub.2 and R.sub.3, independently, are straight or branched chain C.sub.2-8 alkylene radicals, the OH groups being bound other than onto the carbon atoms adjacent the n...

The present invention relates to a pharmaceutical composition comprising aggregates of diameter of at most 20,000 A, comprising: Component (a) comprising at least one pharmaceutically acceptable active agent, and Component (b) comprising at least one pharmaceutically acceptable emulsifier, Component (b) having a mean HLB value of 10 to 30 and present in an amount greater than 10 times by weight of component (a). The composition has enhanced resorption properties.

This invention provides new antibiotics produced by cultivating a strain of the fungus species, Cylindrocarpon lucidum Booth or Tolypocladium inflatum Gams in contact with a nutrient medium, the antibiotics being useful anti-inflammatory and immunosuppressive agents.

Propanoic acid derivatives of formula: ##STR1## where X represents a ketonic or hydroxylic function, R.sup.1 is a C.sub.1.sub.-8 alkyl group optionally substituted by hydroxy or --COOH and R.sup.2 is hydrogen or a protecting group, having spasmolytic activity.

This invention provides new compounds of formula I, ##STR1## wherein X is hydrogen or halogen having an atomic number from 9 to 35 in the 10- or 11-position, and R is a radical of the series OR.sub.1, SR.sub.2, NR.sub.3 R.sub.4, wherein R.sub.1 and R.sub.2 are alkyl of 1 to 4 carbon atoms, hydroxyalkyl or aminoalkyl of 2 to 4 carbon atoms, phenyl or phenylalkyl of 7 to 10 carbon atoms in the aggregate thereof, and R.sub.3 and R.sub.4 are, independently, hydrogen, alkyl of 1 to 4 carbon atoms, ph...

The present invention concerns novel 2-(1-piperazinyl)-thiazole derivatives of the formula, ##STR1## wherein R.sub.1 is alkyl or cycloalkly, R.sub.2 is hydrogen or alkyl, and R.sub.3 is benzyl, alkoxyalkyl or alkoxycarbonyl, or alkyl, alkenyl, alkanoyl or hydroxyalkyl, or acyloxyalkyl, Useful as vigilance increasing agents, anorexigenic agents and anti-migraine agents.

This invention provides new compounds of formula I, ##STR1## wherein X is H-Ala, D-Ala, .beta.-Ala, propionyl or Ac-Ala (wherein Ac is pharmaceutically acceptable acyl), Y is hydrogen or a direct bond between the sulphur atoms in positions 3 and 14, and Z is the radical --COOH, --COOR.sub.1 (wherein R.sub.1 is lower alkyl), ##STR2## (wherein R.sub.2 and R.sub.3 independently are hydrogen or lower alkyl) or --CH.sub.2 OH, with the proviso that X is other than H-Ala, when Z is COOH. useful as agen...

This invention provides new compounds of formula I, ##STR1## wherein R.sub.1 is hydrogen, halogen of atomic number from 9 to 35 or lower alkyl, R.sub.2 is hydrogen or lower alkyl, each of R.sub.3 and R.sub.4 is hydrogen, or R.sub.3 and R.sub.4 together are oxygen, N is 2, 3 or 4, and A is ethylene or vinylene, Useful as antiphlogistics and anti-arthritics.

The present invention is related to an organic composite. This organic composite comprises a substrate having an organic material surface and a film formed on the substrate by such plasma CVD method. Said organic material have an unsaturated bond of carbon. This organic composite gives an improved performance in an adhesion between the film and the substrate.

The analgesic use of compounds of formula I ##STR1## wherein R is hydrogen, acetyl or a group of formula II wherein R' is alkyl (C.sub.1-8); phenyl; phenyl substituted in the 4-position with halogen, alkoxy(C.sub.1-4) or alkyl(C.sub.1-4); phenylalkyl; or phenylalkyl in which the phenyl group is substituted in the 4-position with halogen, alkoxy(C.sub.1-4) or alkyl (C.sub.1-4).